Ontuxizumab
- Generic Name
- Ontuxizumab
- Drug Type
- Biotech
- CAS Number
- 946415-62-9
- Unique Ingredient Identifier
- 0M2XT000YC
- Background
Ontuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1). It is under investigation in clinical trial NCT01574716 (Sarcoma Study of Morab-004 Utilization: Research and Clinical Evaluation).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath